A new bone‐inducing biodegradable porous β‐tricalcium phosphate
- 25 June 2004
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 70A (3) , 450-458
- https://doi.org/10.1002/jbm.a.30102
Abstract
A new type of degradable biomaterial with bone-inducing capacity was made by combining porous β-tricalcium phosphate (β-TCP) with a delivery system for recombinant human bone morphogenetic protein-2 (rhBMP-2). The BMP delivery system consisted of a block copolymer composed of poly-D,L-lactic acid with random insertion of p-dioxanone and polyethylene glycol (PLA-DX-PEG), a known biocompatible and biodegradable material. The efficacy of this biomaterial in terms of its bone-inducing capacity was examined by ectopic bone formation in the dorsal muscles of the mouse. In the β-TCP implants coated with the PLA-DX-PEG polymer containing more than 0.0025% (w/w) of rhBMP-2, new ectopic bone tissues with marrow were consistently found on the surface of implants. The radiographic density of β-TCP was diminished in a time-dependent manner. On histological examination, numerous multinucleated osteoclasts with positive tartrate-resistant acid-phosphatase (TRAP) staining were noted on the surface of the β-TCP. These experimental results indicate that β-TCP implants coated with synthetic rhBMP-2 delivery system might provide effective artificial bone-graft substitutes with osteoinductive capacity and biodegradable properties. In addition, this type of biomaterial may require less rhBMP-2 to induce significant new bone mass. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res 70A: 450–458, 2004Keywords
This publication has 15 references indexed in Scilit:
- Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriersBone, 2003
- Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrierPublished by Elsevier ,2003
- Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in HumansSpine, 2002
- Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein‐2 (rhBMP‐2) and a synthetic polymerJournal of Biomedical Materials Research, 2002
- Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograftJournal of Orthopaedic Science, 2002
- Histological examination of β‐tricalcium phosphate graft in human femurJournal of Biomedical Materials Research, 2002
- The role of ß-tricalcium phosphate in vascularized periosteumJournal of Orthopaedic Science, 2000
- Bone Graft MaterialsClinical Orthopaedics and Related Research, 2000
- Effective Doses of Recombinant Human Bone Morphogenetic Protein-2 in Experimental Spinal FusionSpine, 1996
- Bone Regeneration under the Influence of a Bone Morphogenetic Protein (BMP) Beta Tricalcium Phosphate (TCP) Composite in Skull Trephine Defects in DogsClinical Orthopaedics and Related Research, 1987